Home Diagnostics, Inc. (NASDAQ:HDIX), a leading manufacturer and marketer of diabetes testing supplies, announced today that Joseph Capper, President and Chief Executive Officer, and Ronald Rubin, Chief Financial Officer, of Home Diagnostics are scheduled to present at the Canaccord Adams Diabetes and Obesity Conference at the InterContinental Barclay Hotel in New York, NY on Tuesday, May 12, 2009, at 2:40 p.m. ET.

A live Web cast of the presentation will be available on the Home Diagnostics Web site at www.homediagnostics.com. A replay of the Web cast will be available following the live presentation and will remain on the site for 30 days.

About Home Diagnostics, Inc.

Based in Fort Lauderdale, Florida, Home Diagnostics, Inc. (NASDAQ: HDIX) is a leading developer, manufacturer and marketer of diabetes management solutions. Home Diagnostics, Inc. offers a portfolio of high-quality blood glucose monitoring systems that spans the spectrum of features and benefits to help every person with diabetes better monitor and manage their disease. The Home Diagnostics, Inc. product line includes TRUE2go™, TRUEresult™, TRUEtrack®, Sidekick®, TRUEread™ and Prestige Smart System® blood glucose monitoring systems. The products are available in more than 45,000 pharmacies throughout the U.S. Home Diagnostics is the exclusive co-brand supplier of blood glucose monitoring supplies for leading pharmacies including CVS, Rite Aid and Walgreens as well as national distributors such as AmerisourceBergen, Cardinal Health, McKesson and Invacare. Home Diagnostics, Inc. was named one of Forbes magazine’s “200 Best Small Companies” in 2008. For more information please visit www.homediagnostics.com.

TRUE2go, TRUEresult, TRUEtest, TRUEtrack, Sidekick, TRUEread and Prestige Smart System are trademarks of Home Diagnostics, Inc. All other trademarks are property of their respective owners.

[HDIX-F]

Home Diagnostics, Fort Lauderdale
Sabrina Rios, Corporate Communications Manager, 954-332-2141
srios@hdidiabetes.com
or
The Ruth Group
Nick Laudico (investors), 646-536-7030
nlaudico@theruthgroup.com